ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Regístrate

¿Ya eres miembro? Iniciar sesión

Los Principales Corredores en Línea

Más Corredores en Línea

Datos
Noticias
Herramientas
Mercados
Descubrir

Hot Features

Follow Feed

Conéctese con traders e inversores en nuestra comunidad Follow Feed.

Flujo de Opciones

Explora datos de opciones completos y utiliza filtros avanzados con Options Flow.

Monitor

Organiza y monitorea tu lista de seguimiento de acciones y activos con Monitor.
Iniciar Sesión Premium IconPremium Help Menu
S&P 500
5,306.04
0.02%
Dow Jones
38,852.86
-0.55%
US Dollar vs MXN
16.80585
0.85%
Brent Oil
84.245
1.69%
Bitcoin
68,367.47
-1.48%
Registration Strip Icon for default Regístrate gratis para obtener cotizaciones en tiempo real, gráficos interactivos, flujo de opciones en vivo y más.
Regístrate
  1. Inicio
  2. Invertir
  3. Acciones
  4. Estados Unidos
  5. NASDAQ
  6. Iovance Biotherapeutics Inc (IOVA)

  7. Iovance Biotherapeutics Inc (IOVA) Noticias

IOVA

Iovance Biotherapeutics (IOVA)

Iovance Biotherapeutics Inc
Fecha:
Ordernar por:
 Showing the most relevant articles for your search:NASDAQ:IOVA
FechaHoraFuenteTítuloSímboloCompañía
24/05/202415:01GlobeNewswire Inc.Iovance Biotherapeutics to Present at Upcoming Conferences and EventsNASDAQ:IOVAIovance Biotherapeutics Inc
23/05/202416:00GlobeNewswire Inc.Iovance Biotherapeutics Announces Clinical Data in Frontline Advanced Melanoma at ASCO 2024 Annual MeetingNASDAQ:IOVAIovance Biotherapeutics Inc
17/05/202416:15Edgar (US Regulatory)Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) materialNASDAQ:IOVAIovance Biotherapeutics Inc
17/05/202416:15GlobeNewswire Inc.Iovance Biotherapeutics Reports Inducement Grants under NASDAQ Listing Rule 5635(c)(4)NASDAQ:IOVAIovance Biotherapeutics Inc
09/05/202416:10Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:IOVAIovance Biotherapeutics Inc
09/05/202415:06Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:IOVAIovance Biotherapeutics Inc
09/05/202415:01GlobeNewswire Inc.Iovance Biotherapeutics Reports First Quarter 2024 Financial Results and Corporate UpdatesNASDAQ:IOVAIovance Biotherapeutics Inc
01/05/202405:01GlobeNewswire Inc.Iovance Biotherapeutics to Host First Quarter 2024 Financial Results Conference Call and Webcast on Thursday, May 9, 2024NASDAQ:IOVAIovance Biotherapeutics Inc
30/04/202405:01GlobeNewswire Inc.Iovance Biotherapeutics to Present at Upcoming ConferencesNASDAQ:IOVAIovance Biotherapeutics Inc
24/04/202415:01GlobeNewswire Inc.Iovance Biotherapeutics to Present Clinical and Translational Data at 2024 ASCO Annual MeetingNASDAQ:IOVAIovance Biotherapeutics Inc
06/03/202417:17Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:IOVAIovance Biotherapeutics Inc
04/03/202405:30GlobeNewswire Inc.Iovance Biotherapeutics Announces FDA has Lifted Clinical Hold on the IOV-LUN-202 Registrational Trial in Non-Small Cell Lung CancerNASDAQ:IOVAIovance Biotherapeutics Inc
28/02/202415:01GlobeNewswire Inc.Iovance Biotherapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Corporate Updates NASDAQ:IOVAIovance Biotherapeutics Inc
22/02/202407:45GlobeNewswire Inc.Iovance Biotherapeutics to Host Fourth Quarter and Full-Year 2023 Financial Results Conference Call and Webcast on Wednesday, February 28, 2024NASDAQ:IOVAIovance Biotherapeutics Inc
21/02/202415:44Edgar (US Regulatory)Form 424B5 - Prospectus [Rule 424(b)(5)]NASDAQ:IOVAIovance Biotherapeutics Inc
20/02/202405:30GlobeNewswire Inc.Iovance Biotherapeutics, Inc. Announces Pricing of $211 Million Underwritten Offering of Common StockNASDAQ:IOVAIovance Biotherapeutics Inc
16/02/202414:38GlobeNewswire Inc.Iovance Biotherapeutics to Host Conference Call and Webcast on Friday, February 16, 2024NASDAQ:IOVAIovance Biotherapeutics Inc
16/02/202414:19GlobeNewswire Inc.Iovance’s AMTAGVI™ (lifileucel) Receives U.S. FDA Accelerated Approval for Advanced MelanomaNASDAQ:IOVAIovance Biotherapeutics Inc
14/02/202405:16Edgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]NASDAQ:IOVAIovance Biotherapeutics Inc
28/12/202306:27IH Market NewsWall Street Highlights: Amazon to Introduce Ads on Prime Video, JD.com Raises Salaries in 2024, and MoreNASDAQ:IOVAIovance Biotherapeutics Inc
27/12/202306:54Dow Jones NewsIovance Shares Fall Premarket As FDA Places Study On Hold After Patient DeathNASDAQ:IOVAIovance Biotherapeutics Inc
27/12/202306:00GlobeNewswire Inc.Iovance Biotherapeutics Announces Clinical Program Update for LN-145 in Non-Small Cell Lung CancerNASDAQ:IOVAIovance Biotherapeutics Inc
07/11/202315:01GlobeNewswire Inc.Iovance Biotherapeutics Reports Third Quarter and Year-to-Date 2023 Financial Results and Corporate UpdatesNASDAQ:IOVAIovance Biotherapeutics Inc
31/10/202315:01GlobeNewswire Inc.Iovance Biotherapeutics to Host Third Quarter and Year-to-Date 2023 Financial Results Conference Call and Webcast on Tuesday, November 7, 2023NASDAQ:IOVAIovance Biotherapeutics Inc
31/10/202308:05GlobeNewswire Inc.Iovance Biotherapeutics to Present Clinical and Pre-Clinical Data for Tumor Infiltrating Lymphocyte (TIL) Therapies at Society for Tumor Immunotherapy of Cancer’s (SITC) 38th Annual MeetingNASDAQ:IOVAIovance Biotherapeutics Inc
16/10/202307:15GlobeNewswire Inc.Iovance Biotherapeutics Announces Clinical Data for Lifileucel in Advanced Mucosal Melanoma at the European Society for Medical Oncology (ESMO) CongressNASDAQ:IOVAIovance Biotherapeutics Inc
14/09/202317:10GlobeNewswire Inc.U.S. Food and Drug Administration Updates Prescription Drug User Fee Act (PDUFA) Action Date for Lifileucel for the Treatment of Advanced MelanomaNASDAQ:IOVAIovance Biotherapeutics Inc
07/09/202306:31GlobeNewswire Inc.Iovance Biotherapeutics to Present at 2023 Wells Fargo Healthcare ConferenceNASDAQ:IOVAIovance Biotherapeutics Inc
08/08/202315:01GlobeNewswire Inc.Iovance Biotherapeutics Reports Second Quarter and First Half 2023 Financial Results and Corporate UpdatesNASDAQ:IOVAIovance Biotherapeutics Inc
25/07/202315:01GlobeNewswire Inc.Iovance Biotherapeutics to Present Clinical Data for Tumor Infiltrating Lymphocyte (TIL) Therapy at IASLC 2023 World Conference on Lung CancerNASDAQ:IOVAIovance Biotherapeutics Inc
 Showing the most relevant articles for your search:NASDAQ:IOVA

Su Consulta Reciente

BIT
XDW0
Xtrackers Msci World Ene...
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

México
Empresa
Negocios
Popular
Obtener la aplicación
App Store
Google Play

Soporte: (55) 4170 8128 | soporte@advfn.mx

Al acceder a los servicios disponibles de ADVFN usted acepta quedar sujerto a los Términos y Condiciones

© 2024 ADVFN PLC - Todos los derechos reservados